Novo Nordisk A/S (NOVO:CA) Analyst/Investor Day Transcript

Novo Nordisk A/S ( NOVO:CA ) Analyst/Investor Day September 21, 2026 4:00 AM EDT Company Participants Maziar Doustdar - President, CEO & Member of the Management Board Martin Lange - EVP of R&D, Chief Scientific Officer and Member of the Management Board Mishal Patel Hong Chow - Executive VP of Product & Portfolio Strategy and Member of Management Board Daniel Bohsen Michael Novod - Senior VP & Head of Investor Relations Habib Bennaceur Jamey Millar - Executive VP of US Operations & Member of Management Board Edward Cinca Emil Larsen - EVP of International Operations & Member of Management Board Kasper Mejlvang - Executive Vice President of CMC & Product Supply Karsten Knudsen - Executive VP, CFO & Member of the Management Board Thilde Bogebjerg - Executive VP of Enterprise IT & Quality and Member of Management Board Tania Sabroe - EVP of People, Organisation and Corporate Affairs & Member of Management Board Conference Call Participants Richard Vosser - JPMorgan Chase & Co, Research Division Seamus Fernandez - Guggenheim Securities, LLC, Research Division Michael Leuchten - Jefferies LLC, Research Division Sachin Jain - BofA Securities, Research Division Simon Baker - Rothschild & Co Redburn, Research Division Florent Cespedes - ODDO BHF Corporate & Markets, Research Division Kerry Holford - Joh. Berenberg, Gossler & Co. KG, Research Division Carsten Madsen - Danske Bank A/S, Research Division Graham Glyn Parry - Citigroup Inc., Research Division Thibault Boutherin - Morgan Stanley, Research Division James Gordon - Barclays Bank PLC, Research Division Rajesh Kumar Peter Verdult - BNP Paribas, Research Division Rune Dahl - DNB Carnegie, Research Division Emmanuel Papadakis - Deutsche Bank AG, Research Division Conversation Operator Welcome to Novo's Capital Markets Day. Before we begin, we need to advise you that this event will contain forward-looking statements. These are subject to risks and uncertainty that could cause actual results to differ materially from expectations. For further information on the risk factors, please refer to this disclaimer, which will also be available on our website.